Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Gastro-enteropancreatic neuroendocrine tumor × Copper × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Gastrointestinal 1 Endocrine 1

Conditions

Neuroendocrine Tumors 1 Gastro-enteropancreatic neuroendocrine tumor 1 Carcinoma, Neuroendocrine 1

Interventions

regorafenib 1 copper dotatate CU-64 1 Irinotecan 1 Fluorodeoxyglucose F18 1 Etoposide 1 Copper 1 Clinical Trials, Phase II as Topic 1 Cisplatin 1 64Cu-DOTATATE 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05709171 2023-11-22

Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms

Rigshospitalet, Denmark

Phase 2 Unknown

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡